News
Podcast
Author(s):
Explore the latest insights on emerging antibody drug conjugates for HER2 breast cancer and real-world management strategies.
In this episode of the Pharmacy Times Peer Exchange feature series about antibody drug conjugates (ADCs) and human epidermal growth factor receptor 2 (HER2) breast cancer (BC), oncology pharmacists discuss novel, emerging ADCs and real-world management of these therapies.